MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress » Rating Scales

Date: Tuesday, September 24, 2019

Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Meeting: 2019 International Congress

1:45pm-3:15pm
“Best practice” guidelines for the collection and analysis of speech data in patients with Parkinson’s Disease (PD).

E. Tripoliti, L. Ramig (Boulder Colorado, CO, USA)

1:45pm-3:15pm
“UPDRS-meter” – a digital and automatic UPDRS scoring application

Z. Yekutieli, S. Baer-Hassin, V. Livneh, T. Fay-Karmon, S. Israeli-Korn, G. Yahalom (Zichron Yaakov, Israel)

1:45pm-3:15pm
An Informant-based Simple Questionnaire for Executive Function Assessment in Dementia with Lewy Bodies and Alzheimer’s Disease

YS. Liang, GU. Hung, CY. Wei, PY. Chiu (Changhua, Taiwan)

1:45pm-3:15pm
An Internet of Things system for patient empowerment: a case study on measuring patients’ understanding of causal relationships between symptoms and behaviour

L. Karni, M. Memedi, E. Kolkowska, I. Scandurra, P. de Roos, DA. Nyholm, G. Klein (Örebro, Sweden)

1:45pm-3:15pm
Association between the side of onset and the motor and non-motor symptoms in Parkinson’s Disease

J. Silva, R. Guimarães, A. D'Abreu (Campinas, Brazil)

1:45pm-3:15pm
Characteristic Parkinsonism Questionnaire for the Discrimination of Parkinson’s Disease Dementia from Vascular Dementia

PY. Chiu (Changhua, Taiwan)

1:45pm-3:15pm
Community Home Care Nurses Training for Parkinson Disease

ST. Chua, LW. Li, HL. Ng, LT. Tan (Novena, Singapore)

1:45pm-3:15pm
Development and Validation of the Parkinson’s Disease Medication Adherence Scale (PD- MAS)

M. Tosin, B. Oliveira (Niterói, Brazil)

1:45pm-3:15pm
Development of a patient-reported Botulinum Toxin Response Scale (BTRS) for neurological disorders: a feasibility study.

D. Gupta, C. Gao, S. Pullman (Burlington, VT, USA)

1:45pm-3:15pm
Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS) based on Duration of Parkinson’s Disease and Dyskinesia

X. Ren, J. Lin, S. Luo, C. Goetz, G. Stebbins, E. Cubo (Burgos, Spain)

1:45pm-3:15pm
Initial Validation of the Cortical Basal ganglia Functional Scale (CBFS) in two international, multicenter cohorts: 4RTNI and PROSPECT

A. Boxer, P. Wang, H. Morris, G. Stebbins, A. Lang (Toronto, ON, Canada)

1:45pm-3:15pm
MDS Translation Program for MDS-UPDRS and UDysRS

S. Luo, N. Lapelle, P. Martin, C. Goetz, G. Stebbins (Durham, NC, USA)

1:45pm-3:15pm
MDS-UPDRS Part III predictors of Part II Item Scores in PPMI

J. Cedarbaum, Z. Xiao, M. Yang (Cambridge, MA, USA)

1:45pm-3:15pm
Objective assessment of motor states in Parkinson’s disease using partial least squares and smartphone data

M. Memedi, S. Aghanavesi (Borlänge, Sweden)

1:45pm-3:15pm
Predicting the impact of Parkinson’s disease on a patient’s gait: the potential of innovative approaches based on instrumented clinical tests

K. Lebel, C. Duval, E. Goubault, S. Bogard (Montréal, QC, Canada)

1:45pm-3:15pm
Puzzle resolution as cognitive test in Parkinson´s disease patients

C. Borrue-Fernandez, D. Santos-García, J. Pagonabarraga, B. Pascual-Sedano, M. Mata, C. Study Group (Madrid, Spain)

1:45pm-3:15pm
Validation of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson’s Disease

J. Rick, S. Xie, E. Mamikonyan, B. Deck, S. Rudovsky, A. Chen-Plotkin, N. Dahodwala, J. Morley, J. Duda, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

1:45pm-3:15pm
Validation of the Hebrew version of the Unified Dyskinesia Rating Scale (UDysRS)

A. Socher, A. Thaler, H. Shabtai, J. Zitser, T. Shainer, M. Kestenbaum, A. Rosenberg, A. Bar David, A. Ezra, T. Taichman, M. Brozgol, T. Herman, G. Stebbins, C. Goetz, S. Luo, P. Martinez-Martin, N. Giladi, T. Gurevich (Mdrid, Spain)

« View all sessions from the 2019 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley